Pharmaceutical Technology on MSN
MSD ends takeover talks with Revolution Medicines
The two companies reportedly could not agree on a price, leaving pharma’s first potential megadeal of 2026 on ice.
Investment follows a multi-year partnership with RoundTable Healthcare Partners PALM COAST, Fla., Oct. 21, 2025 /PRNewswire/ -- Designs for Health ("DFH" or the "Company"), the number one practitioner ...
NEW YORK & ELIZABETH, N.J.--(BUSINESS WIRE)--Hayward Industries, Inc. (“Hayward” or “the Company”) today announced that a partnership led by CCMP Capital ...
Merck & Co (MSD) has broken ground on its new pharmaceutical manufacturing Centre of Excellence in Virginia, US, amid looming tariff threats from the Trump administration. The $3bn site, which is ...
KENILWORTH, N.J. & MUNICH--(BUSINESS WIRE)--MSD (tradename of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK)), and Rigontec today announced that MSD will acquire Rigontec. Rigontec is a pioneer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results